menu search

Novo nordisk buys blood pressure treatment to bolster diabtetes portfolio

Novo Nordisk (NYSE:NVO) has agreed to buy ocedurenone, a blood pressure drug for with potential applications in cardiovascular and kidney disease, the...

October 16, 2023, 10:44 am

Pfizer's earnings cut was 'sort of telegraphed', says e squared's les funtleyder

Les Funtleyder, E Squared Capital Management healthcare portfolio manager, joins 'Squawk Box' to discuss Pfizer cutting full-year revenue guidance by ...

October 16, 2023, 8:52 am

Gsk cancer immunotherapy receives backing from key ema committee

GSK PLC (LSE:GSK, NYSE:GSK) said its cancer immunotherapy drug, Jemperli (dostarlimab), has been recommended for approval by a key committee at the E...

October 16, 2023, 4:02 am

Gilead sciences stock is cheap, with broad pipeline

Gilead Sciences is a California-based biopharmaceutical company with a $95 billion market cap, known for its t...

October 15, 2023, 9:45 pm

Carmot therapeutics highlights clinical data from its pipeline of treatments for obesity and diabetes at obesityweek®

– CT-388 administered once-weekly resulted in clinically meaningful weight loss and insulin sensitivity over a 4 week treatment period in participan...

October 15, 2023, 4:00 pm

Are ozempic and similar treatments impacting food and beverage stocks? here's what pepsi's cfo said about it

Pepsi's CFO addressed the impacts of Ozempic and its sister treatments on the overall business. These c...

October 14, 2023, 8:03 am

Novo nordisk boosts its guidance on demand for its weight-loss drugs, again

Novo Nordisk (NVO) boosted its guidance for the second time in two months as demand soars for its diabetes tre...

October 13, 2023, 5:05 pm

Alpine immune sciences to present initial clinical data on povetacicept in autoimmune glomerulonephritis in a late breaker poster session at american society of nephrology kidney week 2023

SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative...

October 13, 2023, 9:05 am

Global rheumatoid arthritis market poised for us$ 1.2 billion by 2033: growing prevalence of rheumatoid arthritis boosts market growth, according to persistence market research

Key market drivers of Rheumatoid Arthritis Market: rising prevalence, increased demand for treatments, ...

October 12, 2023, 12:10 pm

Nanoviricides, inc. to present at the partnership opportunities in drug delivery conference in boston on october 16, 2023 at 6:07pm et

SHELTON, CT / ACCESSWIRE / October 12, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), announces that the Company's President, Dr. An...

October 12, 2023, 6:45 am

Ozempic study shakes up market for kidney and insulin treatments

American depositary receipts (ADRs) of Novo Nordisk (NOVO) jumped over 6% in early trading on Wednesday, while shares of kidney dialysis machine and i...

October 11, 2023, 1:05 pm

Conduit pharmaceuticals partners with clinconnect on cocrystal development program for azd1656

Collaboration underscores Conduit’s mission to advance promising treatments by developing assets that...

October 11, 2023, 12:30 pm

Altimmune: a year of disappointment

Altimmune's stock has disappointed shareholders over the past year, with disappointing trial results triggering a significant drop in equity in March ...

October 11, 2023, 3:46 am

An2 therapeutics to present new data for epetraborole at idweek 2023

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing ...

October 11, 2023, 12:01 am

Why shares of 89bio plummeted on tuesday

89bio is a clinical-stage biotech company. It focuses on treatments for liver and cardiometabolic disea...

October 10, 2023, 4:13 pm

Cancer biotechs pique buyout interest: recent deals in focus

The M&A trend of 2023 shows that there is an increasing interest in biotech companies making innovative cancer ...

October 10, 2023, 12:47 pm

Novartis leads funding round for uk alzheimer's specialist

UK-based biotech firm AstronauTx has secured £48 million ($61 million) in a significant Series A funding round, marking a step towards developing ...

October 9, 2023, 2:16 am

Lyra therapeutics' nasal matrix in focus: sniffing out opportunity

Lyra Therapeutics' LYR-220 shows promise in addressing chronic rhinosinusitis, targeting a patient demographic that doesn't respond to current ...

October 9, 2023, 1:20 am

Cervical dysplasia treatment market to achieve us$ 846.2 million valuation by 2033 | future market insights inc.

Innovative cervical dysplasia treatments drive market growth, backed by government programs & patient d...

October 9, 2023, 12:30 am

Eli lilly pipeline of obesity treatments is positioned to pay off beyond just mounjaro, analysts say

Shares of Eli Lilly and Co (NYSE:LLY) rose Friday after analysts at Bank of America reaffirmed its confidence in the company. The firm reiterated its ...

October 6, 2023, 3:01 pm


Search within

Pages Search Results: